Regulator-mandated study finds no link between semaglutide use and pancreatic cancer
Audio narration · Coming soon
A regulator-mandated study presented at the EASD meeting found no association between semaglutide use and pancreatic cancer based on data from Denmark, Sweden, and Norway.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews